Table 1 Definitions of metabolic syndrome according to the NCEP ATP III, IDF, AHA, WHO, and EGIR criteria
Definition of Metabolic Syndrome (MetS) | |||||
|---|---|---|---|---|---|
NCEP | IDF | AHA | WHO | EGIR | |
Definition of MetS | Any 3 of 5 criteria listed below | Increased waist plus any of 2 of other 4 criteria | Any 3 of 5 criteria listed below | IFG, IGT, or IR plus 2 of other 5 criteria | Insulin in top 25% plus 2 of other 4 criteria |
BMI (kg/m2) | -- | -- | -- | >30 | -- |
Abdominal obesity (men/women) | Waist >90/80 | Waist ≧90/80 | Waist ≧90/80 | Waist-to-hip ratio >0.9/0.85 | Waist ≧94/80 |
Triglycerides (nmol/L) | ≧1.7 or drug treatment for this lipid abnormality | ≧1.7 or drug treatment for this lipid abnormality | ≧1.7 or drug treatment for this lipid abnormality | ≧1.7 or drug treatment for this lipid abnormality | >2.0 or drug treatment for this lipid abnormality |
HDL cholesterol (nmol/L) (men/women) | <1.0/1.3 or drug treatment for this lipid abnormality | <1.0/1.3 or drug treatment for this lipid abnormality | <1.0/1.3 or drug treatment for this lipid abnormality | <0.9/1.0 or drug treatment for this lipid abnormality | <1.0 or drug treatment for this lipid abnormality |
Blood pressure (mmHg) | ≧130/≧85 or drug treatment for hypertension | ≧130/≧85 or drug treatment for hypertension | ≧130/≧85 or drug treatment for hypertension | ≧140/≧90 or drug treatment for hypertension | ≧140/≧90 or drug treatment for hypertension |
HOMA-IR | -- | -- | -- | >2.53 | -- |
Fasting glucose (nmol/L) | ≧6.1 | ≧5.6 | ≧5.6 | ≧6.1 | ≧6.1 |
Fasting insulin (pmol/L) | -- | -- | -- | -- | >74.6 (Top 25%) |
Urinary albumin excretion | -- | -- | -- | ≧30 mg/g creatinine | -- |